Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (331-340 of 4,675) with videos related to

Pageof 468
Sort By:
Cancer Discovery|June 8, 2017
Dual HER2 Blockade Helps Prevent Breast Cancer Return
Cancer Discovery|June 24, 2017
UNC Cancer Center Director to Lead NCI
Cancer Discovery|May 11, 2017
Chromosome Instability Drives Tumor Evolution
Cancer Discovery|May 13, 2017
Neoadjuvant Trials in ER<sup>+</sup> Breast Cancer: A Tool for Acceleration of Drug Development and DiscoveryAngel L Guerrero-Zotano, Carlos L Arteaga
Cancer Discovery|April 18, 2018
High TMB Predicts Immunotherapy Benefit
Cancer Discovery|September 24, 2016
Epigenetic Profiling of CUP
Cancer Discovery|September 24, 2016
Pinpointing a Factor in Myeloma Bone Disease
Cancer Discovery|September 25, 2016
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic DiseaseJing Liu, Stephen J Blake, Michelle C R Yong, et al.
Cancer Discovery|May 3, 2017
Optimizing Next-Generation AML Therapy: Activity of Mutant IDH2 Inhibitor AG-221 in Preclinical ModelsDaniel Thomas, Ravindra Majeti
Cancer Discovery|April 28, 2017
PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain VulnerabilityBerkley E Gryder, Marielle E Yohe, Hsien-Chao Chou, et al.
Pageof 468

Showing results (331-340 of 4,675) with videos related to

Sort By:
Pageof 468
Cancer Discovery|June 8, 2017
Dual HER2 Blockade Helps Prevent Breast Cancer Return
Cancer Discovery|June 24, 2017
UNC Cancer Center Director to Lead NCI
Cancer Discovery|May 11, 2017
Chromosome Instability Drives Tumor Evolution
Cancer Discovery|May 13, 2017
Neoadjuvant Trials in ER<sup>+</sup> Breast Cancer: A Tool for Acceleration of Drug Development and DiscoveryAngel L Guerrero-Zotano, Carlos L Arteaga
Cancer Discovery|April 18, 2018
High TMB Predicts Immunotherapy Benefit
Cancer Discovery|September 24, 2016
Epigenetic Profiling of CUP
Cancer Discovery|September 24, 2016
Pinpointing a Factor in Myeloma Bone Disease
Cancer Discovery|September 25, 2016
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic DiseaseJing Liu, Stephen J Blake, Michelle C R Yong, et al.
Cancer Discovery|May 3, 2017
Optimizing Next-Generation AML Therapy: Activity of Mutant IDH2 Inhibitor AG-221 in Preclinical ModelsDaniel Thomas, Ravindra Majeti
Cancer Discovery|April 28, 2017
PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain VulnerabilityBerkley E Gryder, Marielle E Yohe, Hsien-Chao Chou, et al.
Pageof 468